Literature DB >> 19160284

Chinese herbal medicine for premenstrual syndrome.

Zheng Jing1, Xunzhe Yang, Khaled Mk Ismail, Xiaoyan Chen, Taixiang Wu.   

Abstract

BACKGROUND: Traditional Chinese herbal medicines are frequently used to treat premenstrual syndrome (PMS) in China. Until now, their efficacy has not been systematically reviewed.
OBJECTIVES: To evaluate the effectiveness and safety of traditional Chinese herbal medicines in the treatment of women with premenstrual syndrome. SEARCH STRATEGY: We searched MEDLINE (January 1950 to December, 2007), EMBASE (January 1980 to December, 2007), Chinese Biomedical Database (CBM) (January 1975 to December, 2007), China National Knowledge Infrastructure (CNKI) (January 1994 to December, 2007), and the VIP Database (January 1989 to December, 2007). SELECTION CRITERIA: Randomised controlled trials (RCTs) studying the efficacy of traditional Chinese herbal medicine(s) for treatment of the premenstrual syndrome were included. DATA COLLECTION AND ANALYSIS: Two review authors telephoned the original authors of the RCTs to confirm the randomisation procedure, extracted and analysed data from the trials that met the inclusion criteria. MAIN
RESULTS: Two RCT considering 549 women were included. One trial which was identified to be of higher methodological quality demonstrated the therapeutic effectiveness of Jingqianping granule. The other study was considered of lower quality due to the inherent risk of various biases in it. Two studies showed statistically significant differences in elimination of symptoms in proliferative phase and premenstrual phase by taking Jingqianping granule than taking Xiaoyaowan (RR 3.50, 95% CI1.74 to 7.06). Women treated by Cipher decoction had a higher rate of recovery than those taking Co-vitamin B6 capsules (RR 48.99, 95% CI 3.06 to 783.99). AUTHORS'
CONCLUSIONS: It is rare in PMS management that efficacy claims are substantiated by clinical trials. One of the identified trials was well designed and reported on the effectiveness of Jingqianping in the treatment of premenstrual syndrome Qiao 2002. However, currently there is insufficient evidence to support the use of chinese herbal medicine for PMS and further, well controlled, trials are needed before any final conclusions could be drawn.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19160284     DOI: 10.1002/14651858.CD006414.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  7 in total

Review 1.  Selective serotonin reuptake inhibitors for premenstrual syndrome.

Authors:  Jane Marjoribanks; Julie Brown; Patrick Michael Shaughn O'Brien; Katrina Wyatt
Journal:  Cochrane Database Syst Rev       Date:  2013-06-07

Review 2.  Cochrane systematic reviews of Chinese herbal medicines: an overview.

Authors:  Jing Hu; Junhua Zhang; Wei Zhao; Yongling Zhang; Li Zhang; Hongcai Shang
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

3.  WITHDRAWN: Traditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndrome.

Authors:  Denise Adams; Taixiang Wu; Xunzhe Yang; Shusheng Tai; Sunita Vohra
Journal:  Cochrane Database Syst Rev       Date:  2018-10-15

4.  Comparison of Vitex agnus-castus Extracts with Placebo in Reducing Menopausal Symptoms: A Randomized Double-Blind Study.

Authors:  Rozita Naseri; Vahid Farnia; Katayoun Yazdchi; Mostafa Alikhani; Behrad Basanj; Safora Salemi
Journal:  Korean J Fam Med       Date:  2019-05-09

5.  Comparing the Effects of Echinophora-platyloba, Fennel and Placebo on Pre-menstrual Syndrome.

Authors:  Masoumeh Delaram; Soleiman Kheiri; Mohammad Reza Hodjati
Journal:  J Reprod Infertil       Date:  2011-07

6.  Xiangshao Granule Exerts Antidepressive Effects in a Depression Mouse Model by Ameliorating Deficits in Hippocampal BDNF and TrkB.

Authors:  Yi Chen; Jie Liu; Xiaoting Wu; Edouard Collins Nice
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-03       Impact factor: 2.629

7.  Identifying Chinese herbal medicine for premenstrual syndrome: implications from a nationwide database.

Authors:  Hsing-Yu Chen; Ben-Shian Huang; Yi-Hsuan Lin; Irene H Su; Sien-Hung Yang; Jiun-Liang Chen; Jen-Wu Huang; Yu-Chun Chen
Journal:  BMC Complement Altern Med       Date:  2014-06-27       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.